Market Tracker

05/26 6:24am ET

Depomed Inc (NASDAQ:DEPO)

19.97
Delayed Data
As of May 25
 -0.16 / -0.79%
Today’s Change
12.25
Today|||52-Week Range
33.74
+10.15%
Year-to-Date

Today’s Trading

Previous close20.13
Today’s open20.30
Day’s range19.73 - 20.39
Volume1,841,469
Average volume (3 months)2,047,233
Market cap$1.2B
Dividend yield--
Data as of 05/25/2016

Growth & Valuation

Earnings growth (last year)-161.46%
Earnings growth (this year)+70.76%
Earnings growth (next 5 years)+24.00%
Revenue growth (last year)-12.20%
P/E ratioNM
Price/Sales3.18
Price/Book3.88

Competitors

 Today’s
change
Today’s
% change
BGNEBeiGene Ltd+0.21+0.76%
DNAIProNAi Therapeutics ...+0.17+2.86%
OASMOasmia Pharmaceutica...+0.17+3.62%
NEPTNeptune Technologies...+0.04+3.60%
Data as of 05/25/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)$0.27
Annual revenue (last year)$342.7M
Annual profit (last year)-$75.7M
Net profit margin-22.10%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
James A. Schoeneck
CFO, Senior VP &
Head-Investor Relations
August J. Moretti
Corporate headquarters
Newark, California

Forecasts